Drospirenone Only Pills and Cervical Mucus Changes: A Pre- and Post-Bariatric Surgery Study
- Sponsor
- Chulalongkorn University
- Study ID
- NCT06345586
- Status
- Recruiting
Conditions
- Contraception
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - 45 Years
- Healthy Volunteers
- Not accepted
Interventions
- Drospirenone — DRUG4 mg tablet once daily
Study Details
The purpose of this study is to study the effect of Drospirenone on cervical mucus change by modified Insler score, pre-bariatric surgery and post-bariatric surgery
Key Dates
- First listed
- Apr 3, 2024
- Start date
- Apr 18, 2024
- Status verified
- Mar 2026
- Primary completion
- Jul 31, 2026
- Completion
- Jul 31, 2026
Study Design
- Enrollment
- 16 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- BASIC_SCIENCE
Arms
- Experimental: DrospirenoneParticipants received Drospirenone 4 mg tablet orally once daily for 21-28 days
Primary Outcome Measure
Cervical mucus by modified Insler score [ Time Frame: 1 month before and 1 month after bariatric surgery ]
Central Contacts
- Punyawee Utaipatanacheep+668-7515-4003
- Somsook Santibenchakul+669-2265-7273
Related Studies
- Evaluation of the Efficacy, Safety, and Tolerability of LevoCeptPHASE3 · Not Yet Recruiting · Sebela Women's Health Inc. · Berkeley, California
- Implementation of a Patient-centered, Reproductive Planning Decision Support Tool (MyPath) Among Women With Substance Use Disorder in the Immediate Postpartum PeriodRecruiting · University of Pittsburgh · Pittsburgh, Pennsylvania
- Etonogestrel Implant as Emergency ContraceptionPHASE4 · Recruiting · University of Colorado, Denver · Aurora, Colorado
- Levonorgestrel 52 mg IUD for Emergency Contraception and Same-Day StartPHASE4 · Recruiting · University of Utah · San Jose, California